Gilead Uses Merck As Shield In $2.5B Idenix Patent Fight
A Gilead Sciences Inc. attorney told a federal jury in Delaware on Tuesday that Merck & Co. Inc. beat Idenix Pharmaceuticals LLC to the punch on research findings that Idenix claimed...To view the full article, register now.
Already a subscriber? Click here to view full article